Skip to main content
. 2022 Feb 3;12(2):210. doi: 10.3390/jpm12020210

Figure 1.

Figure 1

Schematic representation of signaling pathways involved in the effects of ASIC channels in glioma [67], pancreatic ductal adenocarcinoma (PDAC) [69], hepatocellular cancer (HCC) [70], and colorectal cancer (CRC) [68]. The activation and inhibition pathways are represented by green and red arrows, respectively. EMT: epithelial-mesenchymal transition.